Krishna Institute of Medical Sciences Limited (NSE:KIMS)

India flag India · Delayed Price · Currency is INR
814.00
+0.25 (0.03%)
Jul 10, 2026, 3:30 PM IST
Market Cap326.07B +25.6%
Revenue (ttm)39.05B +28.6%
Net Income2.41B -37.2%
EPS6.03 -37.2%
Shares Out 400.14M
PE Ratio135.14
Forward PE76.84
Dividendn/a
Ex-Dividend Daten/a
Volume405,414
Open816.05
Previous Close813.75
Day's Range809.50 - 824.15
52-Week Range575.80 - 858.00
Beta0.18
AnalystsStrong Buy
Price Target827.19 (+1.62%)
Earnings DateAug 6, 2026

About NSE:KIMS

Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. The company offers arthroscopy and shoulder, cardiology, cardiothoracic and cardiovascular, organ transplant, medical and surgical gastroenterology, hepatology, orthopaedic, neurology, neurosurgery, nephrology, urology, oncology, pediatric, neonatology, obstetrics and gynaecology, fertility, dental science, emergency and critical care, vascular, rehabilitation and physiotherapy services. It also provides pulmonology, ... [Read more]

Sector Healthcare
Founded 1973
Employees 5,264
Stock Exchange National Stock Exchange of India
Ticker Symbol KIMS
Full Company Profile

Financial Performance

In fiscal year 2026, NSE:KIMS's revenue was 39.05 billion, an increase of 28.65% compared to the previous year's 30.35 billion. Earnings were 2.41 billion, a decrease of -37.22%.

Financial Statements

Analyst Summary

According to 16 analysts, the average rating for KIMS stock is "Strong Buy." The 12-month stock price target is ₹827.19, which is an increase of 1.62% from the latest price.

Price Target
₹827.19
(1.62% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Krishna Institute of Medical Sciences Transcript: Q4 25/26

Revenue grew 35% year-over-year in Q4 FY26, but EBITDA margin declined due to new unit ramp-up and insurance empanelment delays. Mature units maintained strong margins, while new units are expected to turn EBITDA positive within a year. Debt reduction and continued expansion in core markets are planned.

7 weeks ago - Transcripts

Krishna Institute of Medical Sciences Quarterly report: Q4 2026

Krishna Institute of Medical Sciences has published its Q4 2026 quarterly earnings report on May 18, 2026.

7 weeks ago - Filings

Krishna Institute of Medical Sciences Slides: Q4 2026

Krishna Institute of Medical Sciences has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 18, 2026.

7 weeks ago - Filings

Krishna Institute of Medical Sciences Transcript: Q3 25/26

Q3 FY 2026 saw record revenue growth of 29.2% YoY, surpassing INR 1,000 crore, despite EBITDA margin compression due to new unit ramp-ups. New hospitals are stabilizing, with break-even targeted in FY 2027, and debt levels expected to moderate as expansion slows.

5 months ago - Transcripts

Krishna Institute of Medical Sciences Quarterly report: Q3 2026

Krishna Institute of Medical Sciences has published its Q3 2026 quarterly earnings report on February 8, 2026.

5 months ago - Filings

Krishna Institute of Medical Sciences Slides: Q3 2026

Krishna Institute of Medical Sciences has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 8, 2026.

5 months ago - Filings

Krishna Institute of Medical Sciences Transcript: Q2 25/26

Revenue grew 23% year-over-year, but EBITDA and margins declined due to ramp-up costs from new hospitals. Management expects margin expansion as new units reach break-even, with ARPOB and specialty mix set to improve. Andhra Pradesh and Telangana clusters remain strong.

8 months ago - Transcripts

Krishna Institute of Medical Sciences Quarterly report: Q2 2026

Krishna Institute of Medical Sciences has published its Q2 2026 quarterly earnings report on November 9, 2025.

8 months ago - Filings

Krishna Institute of Medical Sciences Slides: Q2 2026

Krishna Institute of Medical Sciences has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 9, 2025.

8 months ago - Filings

Krishna Institute of Medical Sciences Transcript: Q1 25/26

Revenue grew 26.8% YoY to INR 879 crore, with EBITDA at INR 200 crore and margin at 22.7%. New units in Thane, Bangalore, and Kerala are ramping up, with initial losses expected to neutralize within 12 months. Net debt stands at INR 2,020 crore, and ARPOB is projected to rise as new facilities mature.

1 year ago - Transcripts

Krishna Institute of Medical Sciences Quarterly report: Q1 2026

Krishna Institute of Medical Sciences has published its Q1 2026 quarterly earnings report on August 7, 2025.

1 year ago - Filings

Krishna Institute of Medical Sciences Slides: Q1 2026

Krishna Institute of Medical Sciences has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on August 7, 2025.

1 year ago - Filings